AstraZeneca (STU:ZEGA) Cyclically Adjusted Book per Share: €0.00 (As of Mar. 2026)


STU:ZEGA AstraZeneca PLC STU:ZEGA
87 GF Score
Price €78.00
GF Value €73.02
! 5 Warning Signs
View Full Analysis

What is AstraZeneca Cyclically Adjusted Book per Share?

AstraZeneca STU:ZEGA +1.30% 87 Cyclically Adjusted Book per Share is €0.00 as of Mar. 2026. GuruFocus rates STU:ZEGA with a GF Score™ of 87/100 and a GF Value™ of €73.02. The stock has 5 warning signs investors should review.

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

AstraZeneca's adjusted book value per share for the three months ended in Mar. 2026 was €13.205. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.00 for the trailing ten years ended in Mar. 2026.

During the past 12 months, AstraZeneca's average Cyclically Adjusted Book Growth Rate was 10.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 8.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 9.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of AstraZeneca was 12.50% per year. The lowest was -0.90% per year. And the median was 5.70% per year.

As of today (2026-07-08), AstraZeneca's current stock price is €78.00. AstraZeneca's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €0.00. AstraZeneca's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of AstraZeneca was 10.10. The lowest was 4.21. And the median was 7.89.


AstraZeneca  (STU:ZEGA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of AstraZeneca was 10.10. The lowest was 4.21. And the median was 7.89.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


AstraZeneca Cyclically Adjusted Book per Share Related Terms


AstraZeneca Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for AstraZeneca's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca Cyclically Adjusted Book per Share Chart

AstraZeneca Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.26 6.84 7.38 8.52 8.79

AstraZeneca Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.54 8.70 8.77 8.79 0.00

STU:ZEGA vs LLY, JNJ, ABBV: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, AstraZeneca's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Cyclically Adjusted PB Ratio falls into.


STU:ZEGA
87GF Score
AstraZeneca PLC STU:ZEGA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AstraZeneca Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AstraZeneca's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=13.205/140.8000*140.8000
=13.205

Current CPI (Mar. 2026) = 140.8000.

AstraZeneca Quarterly Data

Book Value per Share CPI Adj_Book
201606 4.760 101.000 6.636
201609 4.604 101.500 6.387
201612 5.565 102.200 7.667
201703 4.796 102.700 6.575
201706 4.800 103.500 6.530
201709 4.548 104.300 6.140
201712 4.992 105.000 6.694
201803 4.135 105.100 5.540
201806 4.273 105.900 5.681
201809 4.037 106.600 5.332
201812 4.325 107.100 5.686
201903 3.536 107.000 4.653
201906 4.570 107.900 5.963
201909 4.210 108.400 5.468
201912 4.502 108.500 5.842
202003 3.717 108.600 4.819
202006 4.140 108.800 5.358
202009 3.945 109.200 5.087
202012 4.891 109.400 6.295
202103 4.617 109.700 5.926
202106 4.956 111.400 6.264
202109 10.904 112.400 13.659
202112 11.215 114.700 13.767
202203 10.648 116.500 12.869
202206 10.969 120.500 12.817
202209 11.451 122.300 13.183
202212 11.280 125.300 12.675
202303 10.784 126.800 11.975
202306 11.134 129.400 12.115
202309 11.244 130.100 12.169
202312 11.578 130.500 12.492
202403 11.111 131.600 11.888
202406 11.839 133.000 12.533
202409 11.833 133.500 12.480
202412 12.564 135.100 13.094
202503 12.244 136.100 12.667
202506 12.505 138.400 12.722
202509 12.610 138.900 12.782
202512 13.405 139.900 13.491
202603 13.205 140.800 13.205

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.00 mean?
AstraZeneca (STU:ZEGA) has a Cyclically Adjusted Book per Share of €0.00 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on AstraZeneca and its competitors.
Is AstraZeneca's Cyclically Adjusted Book per Share too high?
AstraZeneca's current Cyclically Adjusted Book per Share is €0.00. Overall, AstraZeneca has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does AstraZeneca's Cyclically Adjusted Book per Share compare to LLY and JNJ?
AstraZeneca's Cyclically Adjusted Book per Share of €0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on AstraZeneca and its competitors. AstraZeneca's current Cyclically Adjusted Book per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AstraZeneca stock overvalued right now?
AstraZeneca (STU:ZEGA) has a current Cyclically Adjusted Book per Share of €0.00. The stock's GF Value™ is €73.02, compared to a current price of €78.00 — trading 6.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is €0.00. AstraZeneca's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For AstraZeneca (STU:ZEGA), the current Cyclically Adjusted Book per Share is €0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AstraZeneca (STU:ZEGA) Overvalued in 2026?

Based on GuruFocus' analysis, AstraZeneca stock appears to be overvalued. The current stock price of €78.00 is trading 6.8% above its estimated GF Value™ of €73.02.

Key valuation signals for STU:ZEGA:

  • Cyclically Adjusted Book per Share: €0.00
  • GF Value™: €73.02 vs. price of €78.00 (6.8% above fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the STU:ZEGA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AstraZeneca Business Description

Address 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
87GF Score

Get the complete analysis for STU:ZEGA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€78.00
Price
€73.02
GF Value